Posted on

Newborn Pulse Oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns

General Track – Cycle 1 | Clinical Equipment and Devices

HTA Council Recommendation (as of 09 July 2025)

The HTA Council positively recommends  newborn pulse oximetry as a screening test for CCHD among asymptomatic, apparently healthy newborns for financing of DOH and/or PhilHealth. 


In addition to this, the HTA Council recommends that the Department of Health refer to the WHO-UNICEF  technical specifications when selecting the pulse oximeter for procurement.

(See below for more details)

Relevant Information

  1. Status: With Final HTA Council Recommendation
  2. Topic Assignment: Internal + External Assessment
  3. Policy Question: Should newborn pulse oximetry screening (NPOS)  for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns be included in the National Comprehensive Newborn Screening Policy of the DOH and the Newborn Screening Package of PHIC?
  4. Secretary of Health Decision: Approved for government financing

Evidence and Relevant Documents

Back to Assessments Page